Skip to main content

Lymphoma

Nivolumab Monotherapy as Bridge to Transplant in Patients with Relapsed or Refractory Hodgkin Lymphoma

Wayne Kuznar

Next-Generation BTK Inhibitor Highly Active in Relapsed or Refractory Mantle-Cell Lymphoma

Phoebe Starr

Checkpoint Inhibition Consolidation Therapy Promising in High-Risk Hematologic Malignancies

Charles Bankhead

Charles Bankhead

Maintenance Treatment in Mantle-Cell Lymphoma Extends Survival

Brentuximab Vedotin Improves Responses Lasting 4 Months in Cutaneous T-Cell Lymphoma

Pembrolizumab Produces Durable Responses in Relapsed or Refractory Cutaneous T-Cell Lymphoma

R-CHOP Prevails Over Dose-Adjusted EPOCH-R as Standard of Care for Diffuse Large B-Cell Lymphoma

Obinutuzumab Prolongs Survival in Follicular Lymphoma

Stem-Cell Transplant Safe in HIV-Related Lymphoma

Posttransplant Brentuximab: New Standard in Hodgkin Lymphoma?

Page 2 of 3
Results 11 - 20 of 29